Quick Answer
Centessa Pharmaceuticals plc reported Total Assets of $687.50 million for the year ending 2025.
- Centessa Pharmaceuticals plc showed an increase of +19.2% in Total Assets from 2024 to 2025.
- This data is from Centessa Pharmaceuticals plc's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $643.76 million | Q3 2021: $612.21 million | Q1 2022: $582.19 million | Q2 2022: $521.05 million | Q3 2022: $479.36 million | Q1 2023: $403.86 million | Q2 2023: $392.92 million | Q3 2023: $377.36 million | Q1 2024: $328.17 million | Q2 2024: $398.85 million | Q3 2024: $609.72 million | Q1 2025: $527.85 million | Q2 2025: $492.13 million | Q3 2025: $448.30 million.
- Over the full 6 years of available data (2020 to 2025), Centessa Pharmaceuticals plc's Total Assets has grown by 5,767.5%.
- Historical annual values: Fiscal year 2025: $687.50 million | Fiscal year 2024: $576.80 million | Fiscal year 2023: $360.25 million | Fiscal year 2022: $444.31 million | Fiscal year 2021: $629.64 million | Fiscal year 2020: $11.72 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: